1. Home
  2. Nation
  3. Govt seals deal for 30 cr vaccine doses from Indian firm Biological-E

Govt seals deal for 30 cr vaccine doses from Indian firm Biological-E

By Saima Siddiqui 
Updated Date

Bengaluru: The Union health ministry on Thursday confirmed to have signed a deal with domestic vaccine maker Biological-E for 300 million Covid-19 vaccine doses.

Also Read :- E's Corbevax approved as booster shot for 18 years and above vaccinated with Covaxin, Covishield

The government would be making an advance payment of Rs. 1500 crore to M/s Biological-E for the manufacturing of the vaccines.

The vaccine, a RBD protein sub-unit vaccine, will be manufactured and stockpiled by Biological-E from August-December 2021.

The vaccine, which is currently undergoing phase-3 clinical trials, will likely to be available in the next few months, the health ministry said in a statement.

Biological-E, which also has a separate deal to produce about 600 million doses of Johnson & Johnson’s Covid-19 shot annually, said on Tuesday it entered into a licensing agreement with Providence Therapeutics Holdings to manufacture the Canadian company’s mRNA Covid-19 vaccine in India.

Also Read :- Drugs Controller General of India to review serum applications for children using Covovax today

Biological-E will run a clinical trial of the vaccine in India and seek emergency use approval.

Further reading:
For the latest news and reviews, follow us on Facebook, YouTube and Twitter पर फॉलो करे...